European Banks Draw Scrutiny Over Reciprocity

Related Link: 

Behind the scenes in Europe, banks regularly dole out lucrative work to their competitors, partly based on how much business they will receive in return.

HarperCollins Buys Series from "Divergent" Author

Related Link: 

HarperCollins Publishers has purchased a two-book deal from “Divergent” series author Veronica Roth.

Sotheby's Earnings Fall as Expenses Grow

Related Link: 

Sotheby’s posted an 18.5% drop in earnings due to higher expenses, as the auction house faces pressure from shareholders and searches for a new chief executive.

Vodafone to Launch U.K. TV Services

Related Link: 

Vodafone will launch television services later this year as the wireless telecoms operator tries to boost revenues amid greater competition from incumbent players.

HTC Enters Virtual-Reality Market---Mobile World

Related Link: 

Taiwanese smartphone maker HTC Corp. is entering the world of virtual reality, part of its move to diversify its product line to boost sales.

Endo to Sell Men's Health Businesses to Boston Scientific

Related Link: 

Endo International PLC said Monday that it has agreed to sell its men’s health and prostate businesses to Boston Scientific for $1.6 billion, in a bid to streamline and focus instead on its core pharmaceuticals business.

Abertis Buys Majority Stake in Wind's Telecom Tower Unit

Related Link: 

Spain’s Abertis Infraestructuras said it has agreed to buy 90% of the telecommunication tower business of Italy’s Wind Telecomunicazioni.

Glencore Faces Hit From Big Coal Bet

Related Link: 

Investors will get their first look on Tuesday at a full year of Glencore’s financial results since it acquired Xstrata and its ample coal reserves in 2013. Coal prices are off about 25% since then.

Orange Considers Potential Tie-Up With Telecom Italia

Related Link: 

France’s Orange is considering launching a bid to tie up with Telecom Italia in a sign that European telecommunications companies are continuing to push forward a wave of consolidation across the region.

Amgen Sees Positive Results From Kyprolis Study

Related Link: 

Amgen took a step forward in its efforts to make its Kyprolis cancer therapy a standard treatment for many multiple myeloma patients, saying the drug performed better than older rival Velcade in a study.

Syndicate content